Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study ARA Aiken, PA Lohr, J Lord, N Ghosh, J Starling BJOG: An International Journal of Obstetrics & Gynaecology 128 (9), 1464-1474, 2021 | 213 | 2021 |
Surgical versus medical methods for second trimester induced abortion PA Lohr, JL Hayes, K Gemzell‐Danielsson Cochrane Database of Systematic Reviews, 2008 | 207 | 2008 |
Prevalence and correlates of ambivalence towards pregnancy among nonpregnant women EB Schwarz, PA Lohr, MA Gold, B Gerbert Contraception 75 (4), 305-310, 2007 | 160 | 2007 |
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. R Lyus, P Lohr, S Prager Contraception 81 (5), 367-371, 2010 | 141 | 2010 |
Cervical preparation for first trimester surgical abortion N Kapp, PA Lohr, TD Ngo, JL Hayes Cochrane Database of Systematic Reviews, 2010 | 110 | 2010 |
Modern methods to induce abortion: safety, efficacy and choice N Kapp, PA Lohr Best Practice & Research Clinical Obstetrics & Gynaecology 63, 37-44, 2020 | 85 | 2020 |
Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention MF Reeves, MC Fox, PA Lohr, MD Creinin Ultrasound in Obstetrics and Gynecology 34 (1), 104-109, 2009 | 85 | 2009 |
The impact of COVID-19 on contraception and abortion care policy and practice: experiences from selected countries DJ Bateson, PA Lohr, WV Norman, C Moreau, K Gemzell-Danielsson, ... BMJ Sexual & Reproductive Health 46 (4), 241-243, 2020 | 82 | 2020 |
Use of intrauterine devices in nulliparous women PA Lohr, R Lyus, S Prager Contraception 95 (6), 529-537, 2017 | 64 | 2017 |
RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion H Bracken, PA Lohr, J Taylor, C Morroni, B Winikoff Contraception 90 (1), 29-35, 2014 | 60 | 2014 |
Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure MF Reeves, PA Lohr, BJ Harwood, MD Creinin Obstetrics & Gynecology 111 (1), 106-112, 2008 | 53 | 2008 |
Women's opinions on the home management of early medical abortion in the UK PA Lohr, J Wade, L Riley, A Fitzgibbon, A Furedi BMJ Sexual & Reproductive Health 36 (1), 21-25, 2010 | 50 | 2010 |
Surgical abortion in the second trimester PA Lohr Reproductive health matters 16 (sup31), 151-161, 2008 | 49 | 2008 |
Experiences of women who travel to England for abortions: an exploratory pilot study C Gerdts, S DeZordo, J Mishtal, J Barr-Walker, PA Lohr The European Journal of Contraception & Reproductive Health Care 21 (5), 401-407, 2016 | 42 | 2016 |
Mifepristone and misoprostol for early pregnancy failure: a cohort analysis KM Kollitz, LA Meyn, PA Lohr, MD Creinin American journal of obstetrics and gynecology 204 (5), 386. e1-386. e6, 2011 | 41 | 2011 |
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks’ gestation: a systematic review with meta-analyses M Schmidt-Hansen, S Cameron, PA Lohr, E Hasler American Journal of Obstetrics and Gynecology 222 (6), 551-563. e13, 2020 | 39 | 2020 |
Access to abortion under the heath exception: a comparative analysis in three countries SA Küng, BG Darney, B Saavedra-Avendaño, PA Lohr, L Gil Reproductive health 15, 1-10, 2018 | 38 | 2018 |
Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation JK Hsia, PA Lohr, J Taylor, MD Creinin Contraception 100 (3), 178-181, 2019 | 33 | 2019 |
A comparison of transabdominal and transvaginal ultrasonography for determination of gestational age and clinical outcomes in women undergoing early medical abortion PA Lohr, MF Reeves, MD Creinin Contraception 81 (3), 240-244, 2010 | 33 | 2010 |
Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks’ gestation at British Pregnancy Advisory Service: A … ME Meurice, KC Whitehouse, R Blaylock, JJ Chang, PA Lohr Contraception 104 (1), 61-66, 2021 | 32 | 2021 |